Clinical Trial Update: Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial assessing riluzole for acute anxiolytic effects in adults with social anxiety disorder and performance anxiety; trial completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Performance Anxiety
• Social Anxiety Disorder

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: Yale University | Conditions: Social Anxiety Disorder, Performance Anxiety | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-05-20